Taurine-conjugated bile acids and their link to hepatic S1PR2 play a significant role in hepatitis C-related liver disease

• Published in: Hepatology communications 2024-07, Vol.8 (7)
• Main Authors: Ali, Rabab O, Haddad, James A, Quinn, Gabriella M, Zhang, Grace Y, Townsend, Elizabeth, Scheuing, Lisa, Hill, Kareen L, Menkart, Matthew, Oringher, Jenna L, Umarova, Regina, Rampertaap, Shakuntala, Rosenzweig, Sergio D, Koh, Christopher, Levy, Elliot B, Kleiner, David E, Etzion, Ohad, Heller, Theo
• Format: Article
• Language: English
• Subjects: Adult; Aged; Bile Acids and Salts - blood; Bile Acids and Salts - metabolism; Female; Gastrointestinal Microbiome; Hepatitis C, Chronic - complications; Hepatitis C, Chronic - drug therapy; Hepatitis C, Chronic - metabolism; Humans; Liver - metabolism; Liver Cirrhosis - metabolism; Liver Cirrhosis - virology; Male; Middle Aged; NLR Family, Pyrin Domain-Containing 3 Protein - metabolism; Original; Sphingosine-1-Phosphate Receptors - metabolism; Sustained Virologic Response; Taurine - blood
• ISSN: 2471-254X; 2471-254X
• DOI: 10.1097/HC9.0000000000000478

Bile acids mediate gut-liver cross-talk through bile acid receptors. Serum, hepatic, and microbial bile acid metabolism was evaluated in HCV-compensated chronic liver disease. Patients underwent liver biopsy; portal and peripheral blood were obtained before (HCVi), and 6 months after sustained virologic response (SVR), splenic blood was obtained only after SVR. The fecal microbiome and liver transcriptome were evaluated using RNA-Seq. Twenty-four bile acids were measured in serum, summed as free, taurine-conjugated bile acids (Tau-BAs), and glycine-conjugated bile acids. Compared to SVR, HCVi showed elevated conjugated bile acids, predominantly Tau-BA, compounded in HCVi cirrhosis. In the liver, transcription of bile acids uptake, synthesis, and conjugation was decreased with increased hepatic spillover into systemic circulation in HCVi. There was no difference in the transcription of microbial bile acid metabolizing genes in HCVi. Despite an overall decrease, Tau-BA remained elevated in SVR cirrhosis, mainly in splenic circulation. Only conjugated bile acids, predominantly Tau-BA, correlated with serum proinflammatory markers and hepatic proinflammatory pathways, including NLRP3 and NFKB. Among hepatic bile acid receptors, disease-associated conjugated bile acids showed the strongest association with hepatic spingosine-1-phosphate receptor 2 (S1PR2). Enhanced expression of hepatic S1PR2 in HCVi and HCVi-cirrhosis and strong associations of S1PR2 with Tau-BAs suggest pathological relevance of Tau-BA-hepatic S1PR2 signaling in chronic liver disease. These findings have therapeutic implications in chronic liver diseases.